Cognitive impairment and CSF proteome modification after oral bacteriotherapy in HIV patients.

Claudia LandiLetizia SantinelliLaura BianchiEnxhi ShabaGiancarlo CeccarelliEugenio Nelson CavallariCristian BorrazzoClaudia PinacchioCarolina ScagnolariVincenzo VulloLuca BiniGabriella d'Ettorre

Published in: Journal of neurovirology (2019)

Our results suggest that oral bacteriotherapy as a supplement to cART could exert a role in the amelioration of inflammation state at peripheral and CNS level.

Keyphrases

cognitive impairment
end stage renal disease
ejection fraction
chronic kidney disease
newly diagnosed
oxidative stress
antiretroviral therapy
hiv positive
human immunodeficiency virus
hiv infected
hepatitis c virus
peritoneal dialysis
hiv aids
patient reported outcomes
patient reported